The pretreatment
INTRODUCTION
The ultimate aim in the treatment of acute leukemia is total cure of the patient; the attainment of complete remission is the initial step of this goal. The survival curve for failing patients is almost identical to that of patients receiving supportive care only., The median survival period after relapse is generally less than six months,2 so that once hematologic remission is achieved, the next therapeutic objective is to prevent recurrence of leukemia. In treatment, therefore, it is important to evaluate case charac teristics related to prognoses. Recently the proportion of patients having a five-year survivorship has greatly increased, and a number of studies have been published on pretreatment factors helpful in predicting either the likelihood of achieving complete remission or the duration of remission.3 Complete remission was diagnosed upon the attainment Z 80 points on the Kimura's remission criteria's together with the absence of blasts in the peripheral blood.
The patient characteristics chosen for analysis were recorded at the time of diag nosis, not upon the initiation of chemotherapy. These included morphology, age, sex, body temperature, liver size, hemoglobin level, white blood cell (wbc) count, platelet count, neutrophil alkaline phosphatase (NAP) score and lactic dehydrogenase (LDH) level. To assess the possible association of dichotomous variables with remission inci dence, the proportion of patients who achieved complete remission was computed for the two subgroups defined by each variables. To compare these two proportions, a chi-square test was used. To define clearly the interrelationship between the variables, a correlation-coefficient was computed.
RESULTS
Sixty-seven (67%) of the 85 patients achieved complete remission during the period covered by this study. Remission rates for the morphological diagnoses were as follows: Ll, 12/12 (100%); L2, 5/8 (63%); Ml, 4/10 (40%); M2,25/34 (74%); M3,7/14 (50%); M4,1/3 (33%); M5,3/4 (75%) ( Table 1) . A significantly higher (p<0.05) response rate was found for L1. Remission duration and survival did not significantly differ from each other. Representative data for all patients are shown in Table 2 . The proportions of patients who achieved complete remission for the two subgroups of each variables are shown in Table 3 . The absence of fever was found to be the significant predictive factor (p<0.05) for the achievement of complete re mission, and the hemoglobin level was thought to be associated (p<0.1) with the complete remission rate. Initial LDH levels were correlated with wbc counts and platelet counts with nucleated cell counts in bone marrow ( Table 2 Representative data in all patients Table 3 Response rate by pretreatment characteristics Table 4 Correlation-coefficients between pretreatment characteristics (N=23) We confirmed some of these. A high remission rate was observed among patients with LI, no fever, and a normal hemoglobin level. Leimert et al.11 have reported that LI showed a higher remission rate in adult acute leukemia. Similar trends have been noted in juvenile patients. M2, M4, or the presence of Auer rods have previously been shown to warrant prognoses for myeloid groups.12, Y3 Although the prognostic significance of Auer rods was not comfirmed for our group of patients, a higher response rate for LI was comfirmed. An intriguing ob servation is that although the complete remission rate for L1 was higher (100%) than M3 (50%), the median remission durations were similar. M3 has been reported to have a longer remission duration and a long survival period once complete remission is attained.13,14 While several factors were shown to influence strongly the likelihood of a patient's achieving complete remission , once the disease was in remission, these factors had little or no effect on remission duration or the likelihood of a five-year survival period.15 This effect is operative in such factors as body temperature status, hemoglobin level, and the presence of an antecedent hematologic disorder.
Age has long been thought to affect prognoses adversely,5-10 But Gale et al. re ported a high (84%) remission rate with intensive induction chemotherapy, regardless of a patient's age, suggesting that even elderly patients could tolerate the period of hypoplasia.
We also found no influence of age on complete remission rates . Several previous studies have identified prognostic factors, but all points remain controversial. Studies of the age factor have produced conflicting results. In contrast, the biological characteristics of the disease are more intrusive. In addition to LDH and platelet counts, the association between prognoses and such biological characteristics as chromosome pattern,19 cell markers,20 cell kinetics81 and agar colony growth22 have been clarified through several reports. Understanding of these factors, in conjunction with further technical refinements and multivariate analyses may lead to more accurate prognoses.
